SCHEMBL19686010

SCHEMBL19686010

Cc1coc2cc(N3c4ccccc4[Si](c4ccccc4)(c4ccccc4)c4ccccc43)ccc2c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.37
KDM4E B2RXH2 8/20 0.37
HPGD P15428 4/20 0.37
USP2 O75604 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MAOB P27338 3/20 0.36
RAB9A P51151 6/20 0.34
NPC1 O15118 5/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
MAPT P10636 5/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP3A4 P08684 2/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 3/20 0.34
POLB P06746 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
MAPK1 P28482 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685677 0.91 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDUSP2HSD17B10
SCHEMBL19686012 0.89 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDUSP2HSD17B10
SCHEMBL19685899 0.83 KDM4E (0.32) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL19686105 0.83 KDM4E (0.32) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL19686253 0.80 MEN1 (0.35) ALDH1A1KDM4EHPGDUSP2HSD17B10
SCHEMBL19685898 0.78 ACHE (0.38) ALDH1A1KDM4EMAOBSMN1; SMN2MAPT
SCHEMBL19685735 0.77 MAOB (0.33) ALDH1A1MAOBTP53POLB
SCHEMBL19686009 0.77 ALDH1A1 (0.37) ALDH1A1KDM4EHPGDUSP2HSD17B10
SCHEMBL19686034 0.76 SCN2B (0.32) ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL19685948 0.76 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDUSP2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS ALDH1A1 572/4885KDM4E 1138/4885HPGD 901/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS ALDH1A1 572/4885KDM4E 1138/4885HPGD 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.